who found that KIF5A was abnormally upregulated in hepatocellular carcinoma (LIHC), and its high expression level may be positively correlated with the malignant phenotype of LIHC, suggesting that KIF5A may be associated with LIHC disease progression [33]. Here, KIF5A is linked to hepatocellular carcinoma.